CGTX
NASDAQ · Pharmaceuticals
Cognition Therapeutics Inc
$0.70
-0.04 (-5.57%)
Open$0.72
Previous Close$0.74
Day High$0.72
Day Low$0.65
52W High$1.83
52W Low$0.55
Volume—
Avg Volume449.7K
Market Cap65.33M
P/E Ratio—
EPS$-0.20
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+4,334.3% upside
Current
$0.70
$0.70
Target
$30.96
$30.96
$22.83
$30.96 avg
$36.58
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 14.30M | 12.78M | 15.45M |
| Net Income | 4.19M | 3.83M | 4.28M |
| Profit Margin | 29.3% | 30.0% | 27.7% |
| EBITDA | 6.72M | 5.55M | 6.77M |
| Free Cash Flow | 3.42M | 2.69M | 4.56M |
| Rev Growth | -4.2% | +12.1% | -7.5% |
| Debt/Equity | 0.88 | 0.74 | 0.77 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |